Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | GILDGilead Sciences, Inc. | JNJJohnson & Johnson |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | United States |
| Market cap | $212B | $676B |
| Price | $170.87 | $280.78 |
| Last day | +0.92% | −0.47% |
, a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients.
GILD analysis and Q-Scores →Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
JNJ analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.